The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck
Leadership - Merck
Stock and Other Ownership Interests - Merck
Honoraria - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
Quantitative circulating tumor DNA (ctDNA) assessment in patients (pts) with advanced urothelial carcinoma (UC) treated with pembrolizumab (pembro) or platinum-based chemotherapy (chemo) from the phase 3 KEYNOTE-361 trial.
 
Thomas Powles
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson/Janssen; MashupMD; Merck; Merck Serono; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; MashupMD; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche
 
Wayne Yen-Hwa Chang
Consulting or Advisory Role - AstraZeneca; BMS Brazil; Eisai; Ipsen; Janssen; Merck; MSD; Pfizer
 
Yoshiaki Yamamoto
No Relationships to Disclose
 
José Muñoz-Langa
Speakers' Bureau - GlaxoSmithKline; LEO Pharma
 
Felipe Reyes
No Relationships to Disclose
 
Avivit Peer
Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS; Exelixis; Janssen Oncology; Medison; Merck Serono; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS; Eisai; Janssen-Cilag; Merck Serono; MSD Oncology; Novartis; Pfizer; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; BMS; MSD; Pfizer
Other Relationship - AstraZeneca
 
Evan Y. Yu
Consulting or Advisory Role - AADi; Advanced Accelerator Applications; Bayer; Bristol Myers Squibb; Janssen; Loxo/Lilly; Merck; Oncternal Therapeutics
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Daiichi Sankyo (Inst); Dendreon (Inst); Lantheus Medical Imaging (Inst); Merck (Inst); Seagen (Inst); Surface Oncology (Inst); Taiho Pharmaceutical (Inst); Tyra Biosciences (Inst)
 
Graham Cohen
No Relationships to Disclose
 
Anja Lorch
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS Brazil; Eisai; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen
 
Abhishek Bavle
No Relationships to Disclose
 
Blanca Homet Moreno
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Julia Markensohn
No Relationships to Disclose
 
Mackenzie Edmondson
Employment - Merck
Travel, Accommodations, Expenses - Merck
 
Cai Chen
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Razvan Cristescu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Carol Elaine Pena
Employment - Merck
Stock and Other Ownership Interests - Bayer; Merck
Patents, Royalties, Other Intellectual Property - Patents from work at Bayer as a Bayer employee
 
Jared Lunceford
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Seyda Gunduz
Travel, Accommodations, Expenses - Roche; Valentis Healtcare